Literature DB >> 16836733

Left ventricular mechanical support with the Impella Recover left direct microaxial blood pump: a single-center experience.

Andrea Garatti1, Tiziano Colombo, Claudio Russo, Marco Lanfranconi, Filippo Milazzo, Emanuele Catena, Giuseppe Bruschi, Maria Frigerio, Ettore Vitali.   

Abstract

The Impella Recover left direct (LD) is a new intravascular microaxial blood pump, intended as a short-term mechanical support especially in case of acutely reduced left ventricular function. From September 2002 to October 2004, Impella was used to support 12 patients: six patients were supported as bridge-to-heart transplant (HTx); three patients were treated for fulminant acute myocarditis, and three patients for postcardiotomy low-output syndrome. Mean support time was 8.8 +/- 2.3 days. Overall mortality was 50%. Four patients were successfully HTxed; two patients supported as bridge-to-HTx died on left ventricular assist device. Two patients with myocarditis died of septic shock; two patients in the group of postcardiotomy died of multiorgan failure. The latter two patients were slowly weaned from the device, and at 3-months follow-up showed good improvement of the left ventricular function. Our initial experience with Impella Recover LD as mechanical support for patients in cardiogenic shock of various etiology is promising, yielding a good survival in a population of particularly compromised patients.

Entities:  

Mesh:

Year:  2006        PMID: 16836733     DOI: 10.1111/j.1525-1594.2006.00254.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  9 in total

Review 1.  Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Authors:  Charles Brown; Brijen Joshi; Nauder Faraday; Ashish Shah; David Yuh; Jeffrey J Rade; Charles W Hogue
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

2.  Myocardial depression induced by severe sepsis: successful rescue using extracorporeal cardiopulmonary resuscitation from initial phase of severe sepsis.

Authors:  Tomoko Tomioka; Satoshi Shimada; Yoshitaka Ito; Kanichi Inoue
Journal:  BMJ Case Rep       Date:  2015-07-10

3.  The effect of combined treatment with Impella(®) and landiolol in a swine model of acute myocardial infarction.

Authors:  Isamu Yoshitake; Mitsumasa Hata; Akira Sezai; Satoshi Unosawa; Shinji Wakui; Haruka Kimura; Kin-ichi Nakata; Hiroaki Hata; Motomi Shiono
Journal:  J Artif Organs       Date:  2012-04-13       Impact factor: 1.731

4.  Mechanical circulatory support for advanced heart failure.

Authors:  Chetan B Patel; Kevin M Alexander; Joseph G Rogers
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

5.  The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge).

Authors:  Igor D Gregoric; Leon P Jacob; Saverio La Francesca; Brian A Bruckner; William E Cohn; Pranav Loyalka; Biswajit Kar; O H Frazier
Journal:  Tex Heart Inst J       Date:  2008

6.  Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation.

Authors:  Brian A Bruckner; Leon P Jacob; Igor D Gregoric; Pranav Loyalka; Biswajit Kar; William E Cohn; Saverio La Francesca; Branislav Radovancevic; O H Frazier
Journal:  Tex Heart Inst J       Date:  2008

Review 7.  Sepsis-induced cardiomyopathy.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Julian Gil-Cebrian; Maria J Huertos-Ranchal
Journal:  Curr Cardiol Rev       Date:  2011-08

Review 8.  Temporary mechanical circulatory support: a review of the options, indications, and outcomes.

Authors:  Nisha A Gilotra; Gerin R Stevens
Journal:  Clin Med Insights Cardiol       Date:  2015-02-03

9.  Research focus and theme trend on fulminant myocarditis: A bibliometric analysis.

Authors:  Weimei Yang; Xifei He; Zhaozhao Wang; Lijuan Lu; Ge Zhou; Jie Cheng; Xinying Hao
Journal:  Front Cardiovasc Med       Date:  2022-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.